PECAM1 and neoplasm: They also suppressed tumor angiogenesis by inhibiting the phosphorylation of vascular endothelial growth factor receptor 2 (VEGFR2) and CD31, thereby delaying tumor development in a mouse model of BxPC3 xenograft [217].